Kalamazoo, Michigan – OptiMed Specialty Pharmacy was recently named one of “West Michigan’s Best & Brightest Companies to Work For®.” This awards competition recognizes those companies that deliver exceptional human resource practices, innovative solutions, and an impressive commitment to their employees, creating richer lives and building a stronger workplace.
OptiMed Specialty Pharmacy is proud to announce that its CEO, Andy Reeves, RPh, was recently awarded the Excellence in Innovation award from the Michigan Pharmacists Association (MPA). To be deserving of this award, a pharmacist must demonstrate an innovative pharmacy practice program that resulted in improved patient care. This award highlights the work and efforts of pharmacy pioneers who are re-energizing the pharmacy profession to meet the healthcare needs of tomorrow’s patients.
KALAMAZOO, MICHIGAN – OptiMed Specialty Pharmacy is excited to announce that Steve Trebing, RPh, has been hired as Vice President of Industry Relations & Business Development. Steve brings over 35 years of pharmaceutical, consumer healthcare and diagnostics sales experience to OptiMed. His background includes retail pharmacy practice, pharmaceutical sales and marketing, and diagnostic business experience.
KALAMAZOO, MICHIGAN – A newly constructed 15,000-square-foot facility along 9th Street in Oshtemo Township is the new national headquarters of OptiMed Specialty Pharmacy.
OptiMed Specialty Pharmacy and Captify Health Launch Innovative Patient Management Solution to Reduce Healthcare Costs After Surgery
KALAMAZOO, MICHIGAN – With approximately 30 million operations being performed annually in the United States, OptiMed Specialty Pharmacy, dedicated to delivering excellence and value in healthcare, and Captify Health, a provider of patient education and adherence services, have teamed together to launch a new, revolutionary patient program that aims to lessen complications, improve outcomes and reduce hospitalization costs after surgery.
KALAMAZOO, MICHIGAN – OptiMed Specialty Pharmacy, a privately-held specialty pharmacy headquartered in Kalamazoo, Michigan, announced today the acquisition of the Specialty Pharmacy Business line of Advanced Therapeutics, a leading health care company in California.
KALAMAZOO, MI--(Marketwired - April 23, 2016) - OptiMed Specialty Pharmacy has been selected to dispense the limited distribution drug Cosentyx (secukinumab) manufactured by Novartis Pharmaceutical. Cosentyx is a biologic product that is FDA approved to treat adults with any of the following autoimmune inflammatory disorders: moderate to severe plaque psoriasis, active psoriatic arthritis, or active ankylosing spondylitis.
IN AN ERA OF ESCLATING HEALTH CARE COSTS AND INCREASING DRUG COMPLEXITIES, OptiMed Specialty Pharmacy aims to help patients, providers and stakeholders navigate the intricacies of specialty medication therapy, while keeping patient outcomes at the forefront. OptiMed is able to deliver exceptional patient care services backed by a strong clinical foundation and a commitment to quality throughout the entire organization, as demonstrated by their dual accreditation from URAC and ACHC. OptiMed takes a value-driven approach to specialty patient management. With an increasing national presence, OptiMed is well-poised to leave a positive footprint on the specialty pharmacy market.